Drug intelligence / Profile preview

Lazo Be-Feet

Development stage: Unknown
Lead developer: Hartington Pharmaceutical
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Topical

Overview

Lazo Be-Feet is a topical botanical moisturizing formulation developed by Hartington Pharmaceuticals for dermatological care. It is specifically indicated for the treatment and maintenance of skin on the feet and elbows, areas prone to extreme dryness and hyperkeratosis. The product utilizes a plant-based composition to enhance skin hydration and barrier integrity. It is currently approved and available as part of Hartington's dermatological product line, positioned for the management of localized skin complaints.

Brand names: Lazo Be-Feet

Beyond the preview

Go deeper on Lazo Be-Feet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lazo Be-Feet.

Explore the full profile